Clinical Trial Update: NKTR-102 in Combination With Cetuximab in Patients With Refractory Solid Tumors (Phase 2a) and Metastatic or Locally Advanced Colorectal Cancer (Phase 2b) [Phase 2]

View source ↗

Summary

Phase 2 study results for NKTR-102 in combination with cetuximab in refractory solid tumors and metastatic/locally advanced colorectal cancer have been complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Solid Tumors

Drugs mentioned

• Cetuximab (cetuximab)
• NKTR-102

Snippet

Sponsor: Nektar Therapeutics | Conditions: Tumor, Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-06-14